1	where	_	Where	_	WRB	1	_	_	_	_	_	where.adv	Locative_relation	S-Figure
2	is	_	Is	_	VBZ	1	_	_	_	_	_	_	_	B-Directness
3	buprenorphine	_	UNK	_	NNP	1	_	_	_	_	_	_	_	I-Directness
4	dispensed	_	UNK	_	VBN	1	_	_	_	_	_	_	_	I-Directness
5	to	_	to	_	TO	1	_	_	_	_	_	_	_	I-Directness
6	treat	_	UNK	_	NNP	1	_	_	_	_	_	_	_	I-Directness
7	opioid	_	UNK	_	NNP	1	_	_	_	_	_	_	_	I-Directness
8	use	_	UNK	_	NNP	1	_	_	_	_	_	_	_	I-Directness
9	disorders	_	UNK	_	NNP	1	_	_	_	_	_	_	_	I-Directness
10	?	_	?	_	.	1	_	_	_	_	_	_	_	I-Directness

1	where	_	Where	_	WRB	1	_	_	_	_	_	_	_	O
2	is	_	Is	_	VBZ	1	_	_	_	_	_	_	_	O
3	buprenorphine	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
4	dispensed	_	UNK	_	VBN	1	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
6	treat	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
7	opioid	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
8	use	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
9	disorders	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
10	?	_	?	_	.	1	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	2	_	_	_	_	_	_	_	O
2	role	_	UNK	_	NNP	2	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	S-Degree
4	private	_	Private	_	NNP	2	_	_	_	_	_	_	_	B-Age
5	offices	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
6	,	_	,	_	,	2	_	_	_	_	_	_	_	I-Age
7	opioid	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
8	treatment	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
9	programs	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
10	,	_	,	_	,	2	_	_	_	_	_	_	_	I-Age
11	and	_	and	_	CC	2	_	_	_	_	_	_	_	I-Age
12	substance	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
13	abuse	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
14	treatment	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
15	facilities	_	Facilities	_	NNP	2	_	_	_	_	_	_	_	I-Age
16	in	_	in	_	IN	2	_	_	_	_	_	_	_	I-Age
17	urban	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
18	and	_	and	_	CC	2	_	_	_	_	_	_	_	I-Age
19	rural	_	Rural	_	NNP	2	_	_	_	_	_	_	_	I-Age
20	counties	_	UNK	_	NNP	2	_	_	_	_	_	_	_	I-Age
21	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Age

1	context	_	UNK	_	NN	3	_	_	_	_	_	_	_	B-Manner
2	:	_	:	_	:	3	_	_	_	_	_	_	_	I-Manner
3	opioid	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Manner
4	use	_	use	_	NN	3	_	_	_	_	_	use.n	Ingest_substance	O
5	disorders	_	UNK	_	NNS	3	_	_	_	_	_	_	_	B-Purpose
6	are	_	be	_	VBP	3	_	_	_	_	_	_	_	I-Purpose
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	I-Purpose
8	significant	_	significant	_	JJ	3	_	_	_	_	_	_	_	I-Purpose
9	public	_	public	_	JJ	3	_	_	_	_	_	_	_	I-Purpose
10	health	_	health	_	NN	3	_	_	_	_	_	_	_	I-Purpose
11	problem	_	problem	_	NN	3	_	_	_	_	_	_	_	I-Purpose
12	.	_	.	_	.	3	_	_	_	_	_	_	_	I-Purpose

1	context	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	:	_	:	_	:	3	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
5	disorders	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	3	_	_	_	_	_	_	_	B-Time
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	I-Time
8	significant	_	significant	_	JJ	3	_	_	_	_	_	_	_	I-Time
9	public	_	public	_	JJ	3	_	_	_	_	_	public.a	Secrecy_status	S-Degree
10	health	_	health	_	NN	3	_	_	_	_	_	_	_	B-Phenomenon
11	problem	_	problem	_	NN	3	_	_	_	_	_	_	_	I-Phenomenon
12	.	_	.	_	.	3	_	_	_	_	_	_	_	I-Phenomenon

1	context	_	UNK	_	NN	3	_	_	_	_	_	_	_	B-Name
2	:	_	:	_	:	3	_	_	_	_	_	_	_	I-Name
3	opioid	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Name
4	use	_	use	_	NN	3	_	_	_	_	_	_	_	I-Name
5	disorders	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Name
6	are	_	be	_	VBP	3	_	_	_	_	_	_	_	I-Name
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	I-Name
8	significant	_	significant	_	JJ	3	_	_	_	_	_	_	_	I-Name
9	public	_	public	_	JJ	3	_	_	_	_	_	_	_	I-Name
10	health	_	health	_	NN	3	_	_	_	_	_	health.n	Medical_conditions	S-Degree
11	problem	_	problem	_	NN	3	_	_	_	_	_	_	_	B-Patient
12	.	_	.	_	.	3	_	_	_	_	_	_	_	I-Patient

1	context	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
2	:	_	:	_	:	3	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
5	disorders	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
8	significant	_	significant	_	JJ	3	_	_	_	_	_	_	_	O
9	public	_	public	_	JJ	3	_	_	_	_	_	_	_	O
10	health	_	health	_	NN	3	_	_	_	_	_	_	_	O
11	problem	_	problem	_	NN	3	_	_	_	_	_	problem.n	Predicament	O
12	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	O
3	,	_	,	_	,	4	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	B-Protagonist
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Protagonist
6	approved	_	approve	_	VBD	4	_	_	_	_	_	approve.v	Deny_or_grant_permission	S-Degree
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	B-Manner
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Manner
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Manner
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Manner
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	I-Manner
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Manner
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Manner
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	I-Manner
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	I-Manner
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Manner
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Manner
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Manner
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	I-Manner
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	I-Manner
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Manner
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Manner
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	I-Manner
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Manner
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Manner
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Manner
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	O
29	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	B-Manner
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	I-Manner
3	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Manner
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Manner
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Manner
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	I-Manner
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	I-Manner
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Manner
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Manner
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Manner
11	use	_	use	_	NN	4	_	_	_	_	_	use.n	Ingest_substance	O
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	B-Manner
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Manner
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	I-Manner
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	I-Manner
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Manner
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Manner
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Manner
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	I-Manner
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	I-Manner
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Manner
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Manner
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	I-Manner
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Manner
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Manner
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Manner
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Manner
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	I-Manner
29	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Manner

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	B-Landmark_event
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	I-Landmark_event
3	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Landmark_event
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Landmark_event
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Landmark_event
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	I-Landmark_event
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	I-Landmark_event
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Landmark_event
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Landmark_event
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Landmark_event
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	I-Landmark_event
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Landmark_event
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Landmark_event
14	when	_	when	_	WRB	4	_	_	_	_	_	when.adv	Temporal_collocation	O
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	B-Landmark_event
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Landmark_event
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Landmark_event
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Landmark_event
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	I-Landmark_event
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	I-Landmark_event
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Landmark_event
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Landmark_event
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	I-Landmark_event
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Landmark_event
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Landmark_event
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Landmark_event
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Landmark_event
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	I-Landmark_event
29	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Landmark_event

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	B-Age
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	I-Age
3	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Age
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Age
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Age
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	I-Age
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	I-Age
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Age
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Age
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Age
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	I-Age
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Age
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Age
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	I-Age
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	I-Age
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Age
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Age
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Age
19	who	_	who	_	WP	4	_	_	_	_	_	who.UNK	People	O
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	B-Age
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Age
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Age
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	I-Age
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Age
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Age
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Age
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Age
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	I-Age
29	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Age

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	O
3	,	_	,	_	,	4	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	S-Trajector
22	to	_	to	_	TO	4	_	_	_	_	_	to.prep	Goal	O
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	B-Trajector
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Trajector
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Trajector
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Trajector
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Trajector
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	I-Trajector
29	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Trajector

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	B-Alterant
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	I-Alterant
3	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Alterant
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Alterant
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Alterant
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	I-Alterant
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	I-Alterant
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Alterant
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Alterant
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Alterant
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	I-Alterant
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Alterant
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Alterant
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	I-Alterant
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	I-Alterant
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Alterant
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Alterant
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Alterant
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	I-Alterant
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	B-Dimension
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Dimension
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Dimension
23	treating	_	treat	_	VBG	4	_	_	_	_	_	treat.v	Processing_materials	O
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	S-Manner
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	B-Alterant
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Alterant
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Alterant
28	time	_	time	_	NN	4	_	_	_	_	_	_	_	I-Alterant
29	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Alterant

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	B-Unit
2	2002	_	2002	_	CD	4	_	_	_	_	_	_	_	I-Unit
3	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Unit
4	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Unit
5	fda	_	FDA	_	NNP	4	_	_	_	_	_	_	_	I-Unit
6	approved	_	approve	_	VBD	4	_	_	_	_	_	_	_	I-Unit
7	buprenorphine	_	UNK	_	RP	4	_	_	_	_	_	_	_	I-Unit
8	as	_	a	_	IN	4	_	_	_	_	_	_	_	I-Unit
9	an	_	an	_	DT	4	_	_	_	_	_	_	_	I-Unit
10	opioid	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Unit
11	use	_	use	_	NN	4	_	_	_	_	_	_	_	I-Unit
12	disorder	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Unit
13	treatment	_	treatment	_	NN	4	_	_	_	_	_	_	_	I-Unit
14	when	_	when	_	WRB	4	_	_	_	_	_	_	_	I-Unit
15	prescribed	_	UNK	_	VBN	4	_	_	_	_	_	_	_	I-Unit
16	by	_	by	_	IN	4	_	_	_	_	_	_	_	I-Unit
17	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Unit
18	physicians	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Unit
19	who	_	who	_	WP	4	_	_	_	_	_	_	_	I-Unit
20	were	_	be	_	VBD	4	_	_	_	_	_	_	_	I-Unit
21	limited	_	limit	_	VBN	4	_	_	_	_	_	_	_	I-Unit
22	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Unit
23	treating	_	treat	_	VBG	4	_	_	_	_	_	_	_	I-Unit
24	30	_	30	_	CD	4	_	_	_	_	_	_	_	I-Unit
25	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	I-Unit
26	at	_	at	_	IN	4	_	_	_	_	_	_	_	I-Unit
27	a	_	a	_	DT	4	_	_	_	_	_	_	_	I-Unit
28	time	_	time	_	NN	4	_	_	_	_	_	time.n	Measure_duration	O
29	.	_	.	_	.	4	_	_	_	_	_	_	_	S-Unit

1	in	_	In	_	IN	5	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	5	_	_	_	_	_	_	_	O
3	,	_	,	_	,	5	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	5	_	_	_	_	_	federal.a	Political_locales	O
5	legislation	_	UNK	_	NN	5	_	_	_	_	_	_	_	B-Population
6	raised	_	raise	_	VBD	5	_	_	_	_	_	_	_	I-Population
7	this	_	this	_	DT	5	_	_	_	_	_	_	_	I-Population
8	number	_	number	_	NN	5	_	_	_	_	_	_	_	I-Population
9	to	_	to	_	TO	5	_	_	_	_	_	_	_	I-Population
10	100	_	100	_	CD	5	_	_	_	_	_	_	_	I-Population
11	patients	_	patient	_	NNS	5	_	_	_	_	_	_	_	I-Population
12	.	_	.	_	.	5	_	_	_	_	_	_	_	I-Population

1	in	_	In	_	IN	5	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	5	_	_	_	_	_	_	_	O
3	,	_	,	_	,	5	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
5	legislation	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
6	raised	_	raise	_	VBD	5	_	_	_	_	_	_	_	O
7	this	_	this	_	DT	5	_	_	_	_	_	_	_	S-Subregion
8	number	_	number	_	NN	5	_	_	_	_	_	number.n	Be_subset_of	O
9	to	_	to	_	TO	5	_	_	_	_	_	_	_	B-Manner
10	100	_	100	_	CD	5	_	_	_	_	_	_	_	I-Manner
11	patients	_	patient	_	NNS	5	_	_	_	_	_	_	_	I-Manner
12	.	_	.	_	.	5	_	_	_	_	_	_	_	I-Manner

1	in	_	In	_	IN	5	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	5	_	_	_	_	_	_	_	O
3	,	_	,	_	,	5	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
5	legislation	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
6	raised	_	raise	_	VBD	5	_	_	_	_	_	_	_	O
7	this	_	this	_	DT	5	_	_	_	_	_	_	_	O
8	number	_	number	_	NN	5	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	5	_	_	_	_	_	to.prep	Goal	O
10	100	_	100	_	CD	5	_	_	_	_	_	_	_	O
11	patients	_	patient	_	NNS	5	_	_	_	_	_	_	_	O
12	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	6	_	_	_	_	_	although.scon	Concessive	O
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
16	,	_	,	_	,	6	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	B-Main_assertion
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Main_assertion
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Main_assertion
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Main_assertion
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Main_assertion
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Main_assertion
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Main_assertion
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Main_assertion
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Main_assertion

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	6	_	_	_	_	_	federal.a	Political_locales	O
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	B-Locale
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Locale
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Locale
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Locale
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Locale
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Locale
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Locale
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Locale
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Locale
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Locale
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Locale
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Locale
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Locale
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Locale
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Locale
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Locale
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Locale
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Locale
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Locale
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Locale
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
30	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	S-Group
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	S-Final_value
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	increase.v	Change_position_on_a_scale	S-Degree
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	S-Result
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	B-Manner
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Manner
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Manner
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Manner
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Manner
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Manner
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Manner
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Manner
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Manner
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Manner
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Manner
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Manner
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Manner
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Manner
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Manner
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Manner
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Manner
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Manner
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	O
30	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Degree
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Degree
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Degree
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	B-Entity
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Entity
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Entity
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Entity
8	limits	_	limit	_	NNS	6	_	_	_	_	_	limit.n	Limitation	B-Degree
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Degree
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Degree
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Degree
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Degree
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Degree
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Degree
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Degree
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Degree
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Degree
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Degree
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Degree
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Degree
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Degree
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Degree
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Degree
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Degree
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Degree
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Degree
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Degree
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Degree
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Degree
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Degree

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Added_set
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Added_set
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Added_set
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Added_set
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Added_set
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Added_set
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Added_set
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Added_set
9	further	_	further	_	RBR	6	_	_	_	_	_	further.a	Increment	O
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	B-Increment
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Increment
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Increment
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Increment
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Increment
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Increment
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Increment
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Increment
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Increment
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Increment
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Increment
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Increment
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Increment
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Increment
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Increment
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Increment
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Increment
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Increment
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Increment
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Increment
30	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	B-Dimension
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Dimension
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Dimension
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	expand.v	Cause_expansion	O
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	B-Manner
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Manner
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Manner
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Manner
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Manner
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Manner
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Manner
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Manner
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Manner
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Manner
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Manner
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Manner
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Manner
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Manner
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Manner
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Manner

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Trajector
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Trajector
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Trajector
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Trajector
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Trajector
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Trajector
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Trajector
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Trajector
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Trajector
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Trajector
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Trajector
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Trajector
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Trajector
14	to	_	to	_	TO	6	_	_	_	_	_	to.prep	Goal	O
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	B-Time
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Time
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Time
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Time
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Time
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Time
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Time
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Time
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Time
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Time
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Time
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Time
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Time
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Time
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Time
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Time

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Dimension
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Dimension
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Dimension
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Dimension
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Dimension
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Dimension
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Dimension
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Dimension
17	little	_	little	_	JJ	6	_	_	_	_	_	little.a	Size	S-Degree
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	B-Dimension
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Dimension
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Dimension
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Dimension
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Dimension
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Dimension
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Dimension
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Dimension
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Dimension
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Dimension
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Dimension
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Dimension
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Dimension

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Topic
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Topic
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Topic
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Topic
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Topic
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Topic
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Topic
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Topic
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Topic
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Topic
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Topic
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Topic
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Topic
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Topic
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Topic
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Topic
18	information	_	information	_	NN	6	_	_	_	_	_	information.n	Information	O
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	B-Cognizer
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Cognizer
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Cognizer
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Cognizer
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Cognizer
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	B-Topic
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Topic
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Topic
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Topic
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Topic
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Topic
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Topic

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Topic
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Topic
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Topic
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Topic
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Topic
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Topic
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Topic
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Topic
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Topic
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Topic
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Topic
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Topic
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Topic
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Topic
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Topic
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Topic
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Topic
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Topic
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Topic
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	regard.v	Topic	S-Degree
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	S-Time
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	B-Degree
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Degree
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Degree
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Degree
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Degree
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Degree
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Degree
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Degree

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Influencing_situation
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Influencing_situation
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Influencing_situation
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Influencing_situation
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Influencing_situation
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Influencing_situation
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Influencing_situation
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Influencing_situation
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Influencing_situation
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Influencing_situation
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Influencing_situation
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Influencing_situation
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Influencing_situation
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Influencing_situation
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Influencing_situation
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Influencing_situation
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Influencing_situation
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Influencing_situation
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Influencing_situation
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Influencing_situation
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	S-Degree
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	S-Time
23	impact	_	impact	_	NN	6	_	_	_	_	_	impact.n	Objective_influence	B-Degree
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Degree
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	I-Degree
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Degree
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Degree
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Degree
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Degree
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Degree

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Degree
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Degree
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Degree
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Degree
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Degree
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Degree
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Degree
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Degree
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Degree
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Degree
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Degree
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Degree
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Degree
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Degree
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Degree
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Degree
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Degree
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Degree
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Degree
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	B-Age
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	I-Age
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Age
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	I-Age
24	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	S-Degree
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	B-Age
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	I-Age
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Age
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
29	use	_	use	_	NN	6	_	_	_	_	_	_	_	I-Age
30	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Age

1	although	_	Although	_	IN	6	_	_	_	_	_	_	_	B-Manner
2	federal	_	federal	_	JJ	6	_	_	_	_	_	_	_	I-Manner
3	legislators	_	legislator	_	NNS	6	_	_	_	_	_	_	_	I-Manner
4	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Manner
5	considering	_	consider	_	VBG	6	_	_	_	_	_	_	_	I-Manner
6	increasing	_	increase	_	VBG	6	_	_	_	_	_	_	_	I-Manner
7	these	_	these	_	DT	6	_	_	_	_	_	_	_	I-Manner
8	limits	_	limit	_	NNS	6	_	_	_	_	_	_	_	I-Manner
9	further	_	further	_	RBR	6	_	_	_	_	_	_	_	I-Manner
10	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Manner
11	expanding	_	expand	_	VBG	6	_	_	_	_	_	_	_	I-Manner
12	prescribing	_	UNK	_	VBG	6	_	_	_	_	_	_	_	I-Manner
13	privileges	_	privilege	_	NNS	6	_	_	_	_	_	_	_	I-Manner
14	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Manner
15	unk	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
16	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
17	little	_	little	_	JJ	6	_	_	_	_	_	_	_	I-Manner
18	information	_	information	_	NN	6	_	_	_	_	_	_	_	I-Manner
19	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Manner
20	available	_	available	_	JJ	6	_	_	_	_	_	_	_	I-Manner
21	regarding	_	regard	_	VBG	6	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	6	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	6	_	_	_	_	_	use.n	Ingest_substance	O
30	.	_	.	_	.	6	_	_	_	_	_	_	_	S-Manner

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Instrument
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Instrument
3	examined	_	examine	_	VBD	7	_	_	_	_	_	examine.v	Inspecting	S-Degree
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	B-Time
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Time
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	B-Manner
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Manner
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Manner
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Manner
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Manner
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Manner
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Manner
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Manner
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Manner
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Manner
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Manner
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Manner
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Manner
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Manner
21	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Manner
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Manner
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Manner
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Manner
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Manner
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	B-Purpose
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Purpose
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Purpose
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Purpose
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Purpose
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Purpose
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Purpose
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Purpose
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Purpose
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Purpose
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Purpose
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Purpose
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Purpose
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Purpose
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Purpose

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Degree
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Degree
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Degree
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	S-Time
5	impact	_	impact	_	NN	7	_	_	_	_	_	impact.n	Objective_influence	B-Degree
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Degree
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Degree
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Degree
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Degree
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Degree
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Degree
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Degree
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Degree
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Degree
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Degree
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Degree
21	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Degree
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Degree
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Degree
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Degree
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Degree
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Degree
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Degree
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Degree
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Degree
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Degree
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Degree
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Degree
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Degree
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Degree

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Age
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Age
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Age
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Age
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Age
6	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	S-Degree
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	B-Age
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Age
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Age
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Age
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Age
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Age
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Age
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Age
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Age
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Age
21	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Age
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Age
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Age
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Age
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Age
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Age
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Age
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Age
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Age
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Age
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Age
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Age

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Members
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Members
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Members
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Members
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Members
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Members
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Members
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Members
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Members
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Members
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Members
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Members
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Members
14	association	_	association	_	NN	7	_	_	_	_	_	association.n	Organization	O
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	B-Members
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Members
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Members
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Members
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Members
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Members
21	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Members
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Members
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Members
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Members
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Members
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Members
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Members
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Members
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Members
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Members
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Members
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Members
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Members
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Members
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	O
40	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Constituent_parts
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Constituent_parts
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Constituent_parts
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Constituent_parts
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Constituent_parts
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Constituent_parts
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Constituent_parts
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Constituent_parts
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Constituent_parts
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Constituent_parts
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Constituent_parts
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Constituent_parts
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Constituent_parts
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Constituent_parts
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Constituent_parts
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Constituent_parts
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Constituent_parts
18	rural	_	rural	_	JJ	7	_	_	_	_	_	rural.a	Locale_by_use	I-Constituent_parts
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Constituent_parts
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Constituent_parts
21	,	_	,	_	,	7	_	_	_	_	_	_	_	B-Use
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Use
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Use
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Use
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Use
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Use
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Use
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Use
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Use
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Use
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Use
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Use
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Use
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Use
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Use
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Use
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Use
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Use
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Use
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Use

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Salient_entity
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Salient_entity
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Salient_entity
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Salient_entity
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Salient_entity
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Salient_entity
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Salient_entity
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Salient_entity
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Salient_entity
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Salient_entity
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Salient_entity
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Salient_entity
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Salient_entity
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Salient_entity
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Salient_entity
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Salient_entity
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Salient_entity
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Salient_entity
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Salient_entity
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Salient_entity
21	,	_	,	_	,	7	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	7	_	_	_	_	_	program.n	Project	S-Agent
25	,	_	,	_	,	7	_	_	_	_	_	_	_	B-Manner
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Manner
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Manner
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Manner
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Manner
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Manner
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Manner
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Manner
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Manner
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Manner
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Manner
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Manner
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Manner
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Manner
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Manner
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Manner

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Speed
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Speed
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Speed
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Speed
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Speed
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Speed
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Speed
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Speed
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Speed
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Speed
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Speed
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Speed
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Speed
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Speed
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Speed
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Speed
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Speed
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Speed
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Speed
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Speed
21	,	_	,	_	,	7	_	_	_	_	_	_	_	B-Individuals
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Individuals
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Individuals
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Individuals
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Individuals
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Individuals
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Individuals
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Individuals
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Individuals
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Individuals
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Individuals
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Individuals
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	distribute.v	Dispersal	I-Individuals
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Individuals
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Individuals
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Individuals
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Individuals
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Individuals
39	decade	_	decade	_	NN	7	_	_	_	_	_	_	_	I-Individuals
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Individuals

1	we	_	We	_	PRP	7	_	_	_	_	_	_	_	B-Unit
2	therefore	_	therefore	_	RB	7	_	_	_	_	_	_	_	I-Unit
3	examined	_	examine	_	VBD	7	_	_	_	_	_	_	_	I-Unit
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Unit
5	impact	_	impact	_	NN	7	_	_	_	_	_	_	_	I-Unit
6	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Unit
7	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Unit
8	2006	_	2006	_	CD	7	_	_	_	_	_	_	_	I-Unit
9	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Unit
10	as	_	a	_	RB	7	_	_	_	_	_	_	_	I-Unit
11	well	_	well	_	RB	7	_	_	_	_	_	_	_	I-Unit
12	as	_	a	_	IN	7	_	_	_	_	_	_	_	I-Unit
13	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Unit
14	association	_	association	_	NN	7	_	_	_	_	_	_	_	I-Unit
15	between	_	between	_	IN	7	_	_	_	_	_	_	_	I-Unit
16	urban	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Unit
17	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Unit
18	rural	_	rural	_	JJ	7	_	_	_	_	_	_	_	I-Unit
19	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Unit
20	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Unit
21	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Unit
22	opioid	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Unit
23	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Unit
24	programs	_	program	_	NNS	7	_	_	_	_	_	_	_	I-Unit
25	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Unit
26	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Unit
27	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	I-Unit
28	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Unit
29	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Unit
30	unk	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Unit
31	on	_	on	_	IN	7	_	_	_	_	_	_	_	I-Unit
32	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Unit
33	distributed	_	distribute	_	VBN	7	_	_	_	_	_	_	_	I-Unit
34	per	_	per	_	IN	7	_	_	_	_	_	_	_	I-Unit
35	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Unit
36	over	_	over	_	IN	7	_	_	_	_	_	_	_	I-Unit
37	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Unit
38	past	_	past	_	JJ	7	_	_	_	_	_	_	_	I-Unit
39	decade	_	decade	_	NN	7	_	_	_	_	_	decade.n	Calendric_unit	I-Unit
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Unit

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Gizmo
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Gizmo
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Gizmo
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Gizmo
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Gizmo
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Gizmo
7	level	_	level	_	NN	8	_	_	_	_	_	level.n	Gizmo	O
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	S-Use
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
30	,	_	,	_	,	8	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	B-Use
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Use
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Use
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Use
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Use
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Use
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Use
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Use
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Use
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Use
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Use
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Use
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Use
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Use
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Use
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Use
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Use

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Use
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Use
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Use
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Use
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Use
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Use
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Use
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Use
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Use
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Use
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Use
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Use
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Use
14	level	_	level	_	NN	8	_	_	_	_	_	level.n	Gizmo	O
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	S-Use
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
30	,	_	,	_	,	8	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	S-Subregion
18	number	_	number	_	NN	8	_	_	_	_	_	number.n	Be_subset_of	O
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	B-Manner
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Manner
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Manner
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Manner
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Manner
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Manner
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Manner
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Manner
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Manner
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Manner
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Manner
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Manner
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Manner
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Manner
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Manner
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Manner
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Manner
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Manner
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Manner
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Manner
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Manner
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Manner
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Manner
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Manner
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Manner
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Manner
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Manner
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Manner
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Manner
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Manner
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Manner
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Manner
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Age
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Age
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Age
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
19	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	B-Age
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Degree
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Degree
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Degree
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Degree
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Degree
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Degree
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Degree
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Degree
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Degree
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Degree
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Degree
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Degree
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Degree
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Degree
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Degree
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Degree
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Degree
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Degree
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Degree
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Degree
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Degree
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Degree
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Degree
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Degree
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Degree
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Degree
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Degree
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Degree
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Degree
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Degree
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Degree
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Degree
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Degree
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Degree
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Degree
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Degree
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	8	_	_	_	_	_	use.v	Ingest_substance	O
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	B-Manner
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Manner
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Manner
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Manner
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Manner
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Manner
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Manner
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Manner
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Manner
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Manner
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Manner
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Manner
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Manner
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Manner
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Manner
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Manner
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	B-Value
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Value
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Value
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Value
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Value
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Value
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Value
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Value
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Value
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Value
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Value
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	estimate.v	Estimated_value	O
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	B-Value
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Value
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Value
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-State_of_affairs
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-State_of_affairs
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-State_of_affairs
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-State_of_affairs
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-State_of_affairs
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-State_of_affairs
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-State_of_affairs
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-State_of_affairs
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-State_of_affairs
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-State_of_affairs
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-State_of_affairs
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-State_of_affairs
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-State_of_affairs
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	ordinary.a	Typicality	S-Degree
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	B-State_of_affairs
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-State_of_affairs
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-State_of_affairs
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-State_of_affairs
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-State_of_affairs
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-State_of_affairs
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-State_of_affairs
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-State_of_affairs
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-State_of_affairs
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-State_of_affairs
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-State_of_affairs
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-State_of_affairs
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-State_of_affairs
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-State_of_affairs
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-State_of_affairs

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Parameter
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Parameter
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Parameter
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Parameter
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Parameter
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Parameter
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Parameter
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Parameter
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Parameter
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Parameter
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Parameter
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Parameter
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Parameter
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Parameter
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Parameter
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Parameter
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Parameter
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Parameter
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Parameter
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Parameter
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Parameter
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Parameter
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Parameter
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Parameter
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Parameter
37	squares	_	square	_	NNS	8	_	_	_	_	_	square.n	Compatibility	S-Degree
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	B-Parameter
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Parameter
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Parameter
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Parameter
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Parameter
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Parameter
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Parameter
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Parameter
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Parameter
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Parameter
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Parameter
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Parameter
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Parameter
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Parameter
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Parameter
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Parameter
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Parameter
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Parameter
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Parameter
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Parameter
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Parameter
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Parameter
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Parameter
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Parameter
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Parameter

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Instance
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Instance
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Instance
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Instance
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Instance
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Instance
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Instance
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Instance
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Instance
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Instance
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Instance
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Instance
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Instance
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Instance
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Instance
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Instance
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Instance
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Instance
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Instance
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Instance
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Instance
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Instance
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Instance
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Instance
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Instance
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Instance
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Instance
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Instance
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Instance
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Instance
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Instance
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Instance
39	model	_	model	_	NN	8	_	_	_	_	_	model.n	Exemplar	O
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	B-Type
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Type
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Type
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Type
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Type
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Type
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Type
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Type
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Type
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Type
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Type
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Type
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Type
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Type
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Type
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Type
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Type
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Type
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Type
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Type
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	B-Instance
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Instance
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Instance
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Instance
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Instance
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Instance

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Time
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Time
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Time
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Time
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Time
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Time
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Time
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Time
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Time
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Time
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Time
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Time
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Time
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Time
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Time
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Time
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Time
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Time
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Time
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Time
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	B-Degree
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Degree
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Degree
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Degree
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Degree
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Degree
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Degree
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Degree
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Degree
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Degree
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Degree
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Degree
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Degree
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Degree
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Degree
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Degree
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Degree
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Degree
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	S-Time
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	S-Circumstances
43	effects	_	effect	_	NNS	8	_	_	_	_	_	effect.n	Being_in_effect	S-Degree
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	B-Explanation
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Explanation
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	B-Degree
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Degree
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Degree
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Degree
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Degree
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Degree
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Degree
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Degree
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Degree
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Degree
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Degree
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Degree
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Degree
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Degree
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Degree
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Degree
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Degree
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Degree
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Degree

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Age
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Age
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Age
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Age
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Age
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Age
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Age
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Age
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Age
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Age
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Age
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Age
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Age
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Age
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Age
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Age
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	B-Age
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Age
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Age
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Age
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Age
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Age
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Age
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Age

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Value
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Value
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Value
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Value
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Value
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Value
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Value
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Value
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Value
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Value
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Value
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Value
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Value
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Value
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Value
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Value
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Value
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Value
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Value
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Value
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
30	,	_	,	_	,	8	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	8	_	_	_	_	_	total.a	Amounting_to	O
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Age
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Age
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Age
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Age
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Age
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Age
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Age
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Age
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Age
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Age
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Age
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Age
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Age
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Age
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Age
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Age
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Age
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Age
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Age
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Age
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Age
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Age
57	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	B-Age
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Age
65	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Age

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Manner
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Manner
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Manner
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Manner
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Manner
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Manner
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Manner
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Manner
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Manner
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Manner
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Manner
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Manner
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Manner
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Manner
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Manner
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Manner
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Manner
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Manner
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Manner
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Manner
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Manner
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Manner
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Manner
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Manner
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Manner
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Manner
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Manner
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Manner
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Manner
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	8	_	_	_	_	_	number.n	Be_subset_of	O
62	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	8	_	_	_	_	_	_	_	I-Age
3	using	_	Using	_	VBG	8	_	_	_	_	_	_	_	I-Age
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
5	2011	_	2011	_	CD	8	_	_	_	_	_	_	_	I-Age
6	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
7	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
8	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
9	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
10	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
11	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
13	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
14	level	_	level	_	NN	8	_	_	_	_	_	_	_	I-Age
15	data	_	data	_	NNS	8	_	_	_	_	_	_	_	I-Age
16	on	_	on	_	IN	8	_	_	_	_	_	_	_	I-Age
17	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
18	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
19	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
20	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
21	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
22	physicians	_	UNK	_	NNS	8	_	_	_	_	_	_	_	I-Age
23	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
24	substance	_	substance	_	NN	8	_	_	_	_	_	_	_	I-Age
25	abuse	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
26	treatment	_	treatment	_	NN	8	_	_	_	_	_	_	_	I-Age
27	facilities	_	facility	_	NNS	8	_	_	_	_	_	_	_	I-Age
28	using	_	use	_	VBG	8	_	_	_	_	_	_	_	I-Age
29	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
30	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
31	we	_	we	_	PRP	8	_	_	_	_	_	_	_	I-Age
32	estimated	_	estimate	_	VBD	8	_	_	_	_	_	_	_	I-Age
33	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
34	multivariate	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
35	ordinary	_	ordinary	_	JJ	8	_	_	_	_	_	_	_	I-Age
36	least	_	least	_	JJS	8	_	_	_	_	_	_	_	I-Age
37	squares	_	square	_	NNS	8	_	_	_	_	_	_	_	I-Age
38	regression	_	UNK	_	VBP	8	_	_	_	_	_	_	_	I-Age
39	model	_	model	_	NN	8	_	_	_	_	_	_	_	I-Age
40	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Age
41	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
42	fixed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
43	effects	_	effect	_	NNS	8	_	_	_	_	_	_	_	I-Age
44	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
45	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
46	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
47	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
48	annual	_	annual	_	JJ	8	_	_	_	_	_	_	_	I-Age
49	total	_	total	_	JJ	8	_	_	_	_	_	_	_	I-Age
50	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
51	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	I-Age
52	per	_	per	_	FW	8	_	_	_	_	_	_	_	I-Age
53	capita	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
54	as	_	a	_	IN	8	_	_	_	_	_	_	_	I-Age
55	a	_	a	_	DT	8	_	_	_	_	_	_	_	I-Age
56	function	_	function	_	NN	8	_	_	_	_	_	_	_	I-Age
57	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
58	the	_	the	_	DT	8	_	_	_	_	_	_	_	I-Age
59	state	_	state	_	NN	8	_	_	_	_	_	_	_	I-Age
60	's	_	's	_	POS	8	_	_	_	_	_	_	_	I-Age
61	number	_	number	_	NN	8	_	_	_	_	_	_	_	I-Age
62	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
63	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
65	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Value
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Value
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Value
4	amount	_	amount	_	NN	9	_	_	_	_	_	amount.n	Quantity	O
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	B-Descriptor
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Descriptor
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Descriptor
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	I-Descriptor
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Descriptor
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	I-Descriptor
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	I-Descriptor
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	I-Descriptor
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Descriptor
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Descriptor
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Descriptor
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Descriptor
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Descriptor
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Descriptor
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Descriptor
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Descriptor
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Descriptor

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Age
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Age
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	I-Age
5	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	I-Age
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Age
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Age
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	I-Age
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Age
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	I-Age
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	I-Age
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	I-Age
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Age
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Age
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Age
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Age
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Age
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Age
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Age
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Age
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Age

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Manner
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Manner
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Manner
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	I-Manner
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Manner
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Manner
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Manner
8	has	_	have	_	VBZ	9	_	_	_	_	_	have.v	Possession	I-Manner
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Manner
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	I-Manner
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	I-Manner
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	I-Manner
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Manner
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Manner
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Manner
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Manner
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Manner
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Manner
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Manner
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Manner
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Manner

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Manner
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Manner
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Manner
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	I-Manner
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Manner
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Manner
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Manner
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	I-Manner
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Manner
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	increase.v	Change_position_on_a_scale	S-Degree
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	B-Manner
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	I-Manner
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Manner
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Manner
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Manner
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Manner
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Manner
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Manner
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Manner
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Manner
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Manner

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Figure
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Figure
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Figure
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	I-Figure
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Figure
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Figure
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Figure
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	I-Figure
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Figure
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	I-Figure
11	at	_	at	_	IN	9	_	_	_	_	_	at.prep	Locative_relation	O
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	B-Figure
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Figure
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Figure
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Figure
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Figure
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Figure
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Figure
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Figure
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Figure
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Figure

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
2	:	_	:	_	:	9	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	S-Subregion
17	number	_	number	_	NN	9	_	_	_	_	_	number.n	Be_subset_of	O
18	of	_	of	_	IN	9	_	_	_	_	_	_	_	B-Manner
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Manner
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Manner
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Manner

1	findings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	9	_	_	_	_	_	_	_	I-Age
3	the	_	The	_	DT	9	_	_	_	_	_	_	_	I-Age
4	amount	_	amount	_	NN	9	_	_	_	_	_	_	_	I-Age
5	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Age
6	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Age
7	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Age
8	has	_	have	_	VBZ	9	_	_	_	_	_	_	_	I-Age
9	been	_	be	_	VBN	9	_	_	_	_	_	_	_	I-Age
10	increasing	_	increase	_	VBG	9	_	_	_	_	_	_	_	I-Age
11	at	_	at	_	IN	9	_	_	_	_	_	_	_	I-Age
12	a	_	a	_	DT	9	_	_	_	_	_	_	_	I-Age
13	greater	_	greater	_	JJR	9	_	_	_	_	_	_	_	I-Age
14	rate	_	rate	_	NN	9	_	_	_	_	_	_	_	I-Age
15	than	_	than	_	IN	9	_	_	_	_	_	_	_	I-Age
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Age
17	number	_	number	_	NN	9	_	_	_	_	_	_	_	I-Age
18	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	S-Degree
19	buprenorphine	_	UNK	_	JJ	9	_	_	_	_	_	_	_	B-Descriptor
20	providers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Descriptor
21	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Descriptor

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	S-Subregion
2	number	_	number	_	NN	10	_	_	_	_	_	number.n	Be_subset_of	O
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	B-Manner
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Manner
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Manner
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	I-Manner
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	I-Manner
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	I-Manner
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	I-Manner
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Manner
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Manner
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	I-Manner
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	I-Manner
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	I-Manner
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	I-Manner
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	I-Manner
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Manner
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	I-Manner
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	I-Manner
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	I-Manner
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Manner
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	I-Manner
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
29	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	B-Age
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	I-Age
3	of	_	of	_	IN	10	_	_	_	_	_	of.prep	Age	S-Degree
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	B-Age
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Age
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	I-Age
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	I-Age
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	I-Age
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	I-Age
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Age
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Age
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	I-Age
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	I-Age
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	I-Age
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	I-Age
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	I-Age
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Age
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	I-Age
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	I-Age
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	I-Age
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Age
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	I-Age
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	I-Age
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
29	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	10	_	_	_	_	_	to.prep	Goal	O
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	B-Trajector
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	I-Trajector
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	I-Trajector
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Trajector
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Trajector
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Trajector
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	I-Trajector
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Trajector
29	.	_	.	_	.	10	_	_	_	_	_	_	_	I-Trajector

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	B-Constituent_parts
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	I-Constituent_parts
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Constituent_parts
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Constituent_parts
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	I-Constituent_parts
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	I-Constituent_parts
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	I-Constituent_parts
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	I-Constituent_parts
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Constituent_parts
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	I-Constituent_parts
14	rural	_	rural	_	JJ	10	_	_	_	_	_	rural.a	Locale_by_use	O
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	B-Constituent_parts
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	I-Constituent_parts
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Constituent_parts
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	I-Constituent_parts
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	I-Constituent_parts
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	I-Constituent_parts
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	I-Constituent_parts
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	I-Constituent_parts
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Constituent_parts
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Constituent_parts
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	I-Constituent_parts
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Constituent_parts
29	.	_	.	_	.	10	_	_	_	_	_	_	_	I-Constituent_parts

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	B-Partner_1
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	I-Partner_1
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Partner_1
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Partner_1
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Partner_1
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	I-Partner_1
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	I-Partner_1
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	I-Partner_1
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	I-Partner_1
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Partner_1
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Partner_1
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	I-Partner_1
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	I-Partner_1
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	I-Partner_1
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	I-Partner_1
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	I-Partner_1
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Partner_1
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	I-Partner_1
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	I-Partner_1
20	associated	_	associate	_	VBN	10	_	_	_	_	_	associate.v	Collaboration	S-Degree
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	B-Partners
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	I-Partners
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	B-Degree
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Degree
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Degree
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Degree
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	I-Degree
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Degree
29	.	_	.	_	.	10	_	_	_	_	_	_	_	I-Degree

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	10	_	_	_	_	_	with.prep	Accompaniment	O
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	B-Participants
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	I-Participants
24	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Participants
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Participants
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Participants
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	I-Participants
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Participants
29	.	_	.	_	.	10	_	_	_	_	_	_	_	I-Participants

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	B-Age
2	number	_	number	_	NN	10	_	_	_	_	_	_	_	I-Age
3	of	_	of	_	IN	10	_	_	_	_	_	_	_	I-Age
4	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Age
5	unk	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Age
6	to	_	to	_	TO	10	_	_	_	_	_	_	_	I-Age
7	treat	_	treat	_	VB	10	_	_	_	_	_	_	_	I-Age
8	100	_	100	_	CD	10	_	_	_	_	_	_	_	I-Age
9	patients	_	patient	_	NNS	10	_	_	_	_	_	_	_	I-Age
10	with	_	with	_	IN	10	_	_	_	_	_	_	_	I-Age
11	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Age
12	in	_	in	_	IN	10	_	_	_	_	_	_	_	I-Age
13	both	_	both	_	DT	10	_	_	_	_	_	_	_	I-Age
14	rural	_	rural	_	JJ	10	_	_	_	_	_	_	_	I-Age
15	and	_	and	_	CC	10	_	_	_	_	_	_	_	I-Age
16	urban	_	UNK	_	JJ	10	_	_	_	_	_	_	_	I-Age
17	settings	_	UNK	_	NNS	10	_	_	_	_	_	_	_	I-Age
18	was	_	be	_	VBD	10	_	_	_	_	_	_	_	I-Age
19	significantly	_	significantly	_	RB	10	_	_	_	_	_	_	_	I-Age
20	associated	_	associate	_	VBN	10	_	_	_	_	_	_	_	I-Age
21	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	10	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	10	_	_	_	_	_	_	_	B-Degree
24	of	_	of	_	IN	10	_	_	_	_	_	of.prep	Age	I-Degree
25	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Degree
26	dispensed	_	UNK	_	VBN	10	_	_	_	_	_	_	_	I-Degree
27	per	_	per	_	IN	10	_	_	_	_	_	_	_	I-Degree
28	capita	_	UNK	_	NN	10	_	_	_	_	_	_	_	I-Degree
29	.	_	.	_	.	10	_	_	_	_	_	_	_	I-Degree

1	there	_	There	_	EX	11	_	_	_	_	_	there.adv	Locative_relation	O
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	B-Figure
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Figure
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Figure
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Figure
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Figure
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Figure
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Figure
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Figure
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Figure
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Figure
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Figure
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Figure
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Figure
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Figure
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Figure
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Figure
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Figure
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Figure
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Figure
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Figure

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Q_prop
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Q_prop
3	no	_	no	_	DT	11	_	_	_	_	_	no.art	Quantified_mass	S-Degree
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	B-Q_prop
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Q_prop
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Q_prop
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Q_prop
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Q_prop
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Q_prop
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Q_prop
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Q_prop
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Q_prop
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Q_prop
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Q_prop
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Q_prop
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Q_prop
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Q_prop
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Q_prop
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Q_prop
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Q_prop
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Q_prop

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	11	_	_	_	_	_	association.n	Organization	O
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	B-Members
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Members
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	B-Name
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Name
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Name
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Name
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Name
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Name
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Name
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Name
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Name
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Name
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Name
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Name
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Name
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Name

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Dimension
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Dimension
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Dimension
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Dimension
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Dimension
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Dimension
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	S-Group
8	growth	_	growth	_	NN	11	_	_	_	_	_	growth.n	Cause_expansion	O
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	B-Manner
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Manner
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Manner
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Manner
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Manner
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Manner
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Manner
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Manner
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Manner
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Manner
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Manner

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Age
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Age
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Age
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Age
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Age
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Age
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Age
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Age
9	of	_	of	_	IN	11	_	_	_	_	_	of.prep	Age	S-Degree
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	B-Age
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Age
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Age
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Age
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Age
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Age
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Age
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Age
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Age
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Age
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Age

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	distribute.v	Dispersal	O
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
21	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Part
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Part
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Part
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Part
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Part
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Part
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Part
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Part
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Part
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Part
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Part
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Part
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	S-Subregion
14	number	_	number	_	NN	11	_	_	_	_	_	number.n	Be_subset_of	O
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	B-Manner
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Manner
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Manner
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Manner
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Manner
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Manner
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Manner

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Age
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Age
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Age
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Age
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Age
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Age
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Age
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Age
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Age
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Age
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Age
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Age
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Age
15	of	_	of	_	IN	11	_	_	_	_	_	of.prep	Age	S-Degree
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	B-Duration
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Duration
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Duration
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Duration
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Duration
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Duration

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	11	_	_	_	_	_	with.prep	Accompaniment	O
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	B-Co-participant
19	patient	_	patient	_	NN	11	_	_	_	_	_	_	_	I-Co-participant
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
21	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	11	_	_	_	_	_	_	_	B-Protagonist
2	was	_	be	_	VBD	11	_	_	_	_	_	_	_	I-Protagonist
3	no	_	no	_	DT	11	_	_	_	_	_	_	_	I-Protagonist
4	significant	_	significant	_	JJ	11	_	_	_	_	_	_	_	I-Protagonist
5	association	_	association	_	NN	11	_	_	_	_	_	_	_	I-Protagonist
6	in	_	in	_	IN	11	_	_	_	_	_	_	_	I-Protagonist
7	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Protagonist
8	growth	_	growth	_	NN	11	_	_	_	_	_	_	_	I-Protagonist
9	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Protagonist
10	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	I-Protagonist
11	distributed	_	distribute	_	VBN	11	_	_	_	_	_	_	_	I-Protagonist
12	and	_	and	_	CC	11	_	_	_	_	_	_	_	I-Protagonist
13	the	_	the	_	DT	11	_	_	_	_	_	_	_	I-Protagonist
14	number	_	number	_	NN	11	_	_	_	_	_	_	_	I-Protagonist
15	of	_	of	_	IN	11	_	_	_	_	_	_	_	I-Protagonist
16	physicians	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Protagonist
17	with	_	with	_	IN	11	_	_	_	_	_	_	_	I-Protagonist
18	unk	_	UNK	_	JJ	11	_	_	_	_	_	_	_	I-Protagonist
19	patient	_	patient	_	NN	11	_	_	_	_	_	patient.n	Rashness	B-Degree
20	waivers	_	UNK	_	NNS	11	_	_	_	_	_	_	_	I-Degree
21	.	_	.	_	.	11	_	_	_	_	_	_	_	I-Degree

1	conclusions	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
2	:	_	:	_	:	12	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	12	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	12	_	_	_	_	_	of.prep	Age	S-Degree
7	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	B-Age
8	dispensed	_	UNK	_	VBN	12	_	_	_	_	_	_	_	I-Age
9	are	_	be	_	VBP	12	_	_	_	_	_	_	_	I-Age
10	consistent	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Age
11	with	_	with	_	IN	12	_	_	_	_	_	_	_	I-Age
12	the	_	the	_	DT	12	_	_	_	_	_	_	_	I-Age
13	potentially	_	potentially	_	RB	12	_	_	_	_	_	_	_	I-Age
14	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Age
15	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Age
16	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Age
17	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Age
18	agonists	_	UNK	_	NNS	12	_	_	_	_	_	_	_	I-Age
19	for	_	for	_	IN	12	_	_	_	_	_	_	_	I-Age
20	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Age
21	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Age
22	disorder	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Age
23	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	I-Age
24	,	_	,	_	,	12	_	_	_	_	_	_	_	I-Age
25	though	_	though	_	IN	12	_	_	_	_	_	_	_	I-Age
26	they	_	they	_	PRP	12	_	_	_	_	_	_	_	I-Age
27	also	_	also	_	RB	12	_	_	_	_	_	_	_	I-Age
28	make	_	make	_	VBP	12	_	_	_	_	_	_	_	I-Age
29	their	_	their	_	PRP$	12	_	_	_	_	_	_	_	I-Age
30	misuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Age
31	more	_	more	_	RBR	12	_	_	_	_	_	_	_	I-Age
32	likely	_	likely	_	JJ	12	_	_	_	_	_	_	_	I-Age
33	.	_	.	_	.	12	_	_	_	_	_	_	_	I-Age

1	conclusions	_	UNK	_	NNS	12	_	_	_	_	_	_	_	B-Time
2	:	_	:	_	:	12	_	_	_	_	_	_	_	I-Time
3	the	_	The	_	DT	12	_	_	_	_	_	_	_	I-Time
4	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Time
5	amounts	_	amount	_	NNS	12	_	_	_	_	_	_	_	I-Time
6	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Time
7	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Time
8	dispensed	_	UNK	_	VBN	12	_	_	_	_	_	_	_	I-Time
9	are	_	be	_	VBP	12	_	_	_	_	_	_	_	I-Time
10	consistent	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Time
11	with	_	with	_	IN	12	_	_	_	_	_	_	_	I-Time
12	the	_	the	_	DT	12	_	_	_	_	_	_	_	I-Time
13	potentially	_	potentially	_	RB	12	_	_	_	_	_	_	_	I-Time
14	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Time
15	use	_	use	_	NN	12	_	_	_	_	_	use.n	Ingest_substance	O
16	of	_	of	_	IN	12	_	_	_	_	_	_	_	B-Manner
17	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Manner
18	agonists	_	UNK	_	NNS	12	_	_	_	_	_	_	_	I-Manner
19	for	_	for	_	IN	12	_	_	_	_	_	_	_	I-Manner
20	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Manner
21	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Manner
22	disorder	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Manner
23	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	I-Manner
24	,	_	,	_	,	12	_	_	_	_	_	_	_	I-Manner
25	though	_	though	_	IN	12	_	_	_	_	_	_	_	I-Manner
26	they	_	they	_	PRP	12	_	_	_	_	_	_	_	I-Manner
27	also	_	also	_	RB	12	_	_	_	_	_	_	_	I-Manner
28	make	_	make	_	VBP	12	_	_	_	_	_	_	_	I-Manner
29	their	_	their	_	PRP$	12	_	_	_	_	_	_	_	I-Manner
30	misuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Manner
31	more	_	more	_	RBR	12	_	_	_	_	_	_	_	I-Manner
32	likely	_	likely	_	JJ	12	_	_	_	_	_	_	_	I-Manner
33	.	_	.	_	.	12	_	_	_	_	_	_	_	I-Manner

1	conclusions	_	UNK	_	NNS	12	_	_	_	_	_	_	_	B-Age
2	:	_	:	_	:	12	_	_	_	_	_	_	_	I-Age
3	the	_	The	_	DT	12	_	_	_	_	_	_	_	I-Age
4	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Age
5	amounts	_	amount	_	NNS	12	_	_	_	_	_	_	_	I-Age
6	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Age
7	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Age
8	dispensed	_	UNK	_	VBN	12	_	_	_	_	_	_	_	I-Age
9	are	_	be	_	VBP	12	_	_	_	_	_	_	_	I-Age
10	consistent	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Age
11	with	_	with	_	IN	12	_	_	_	_	_	_	_	I-Age
12	the	_	the	_	DT	12	_	_	_	_	_	_	_	I-Age
13	potentially	_	potentially	_	RB	12	_	_	_	_	_	_	_	I-Age
14	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Age
15	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Age
16	of	_	of	_	IN	12	_	_	_	_	_	of.prep	Age	S-Degree
17	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	B-Age
18	agonists	_	UNK	_	NNS	12	_	_	_	_	_	_	_	I-Age
19	for	_	for	_	IN	12	_	_	_	_	_	_	_	I-Age
20	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Age
21	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Age
22	disorder	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Age
23	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	I-Age
24	,	_	,	_	,	12	_	_	_	_	_	_	_	I-Age
25	though	_	though	_	IN	12	_	_	_	_	_	_	_	I-Age
26	they	_	they	_	PRP	12	_	_	_	_	_	_	_	I-Age
27	also	_	also	_	RB	12	_	_	_	_	_	_	_	I-Age
28	make	_	make	_	VBP	12	_	_	_	_	_	_	_	I-Age
29	their	_	their	_	PRP$	12	_	_	_	_	_	_	_	I-Age
30	misuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Age
31	more	_	more	_	RBR	12	_	_	_	_	_	_	_	I-Age
32	likely	_	likely	_	JJ	12	_	_	_	_	_	_	_	I-Age
33	.	_	.	_	.	12	_	_	_	_	_	_	_	I-Age

1	conclusions	_	UNK	_	NNS	12	_	_	_	_	_	_	_	B-Time
2	:	_	:	_	:	12	_	_	_	_	_	_	_	I-Time
3	the	_	The	_	DT	12	_	_	_	_	_	_	_	I-Time
4	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Time
5	amounts	_	amount	_	NNS	12	_	_	_	_	_	_	_	I-Time
6	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Time
7	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Time
8	dispensed	_	UNK	_	VBN	12	_	_	_	_	_	_	_	I-Time
9	are	_	be	_	VBP	12	_	_	_	_	_	_	_	I-Time
10	consistent	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Time
11	with	_	with	_	IN	12	_	_	_	_	_	_	_	I-Time
12	the	_	the	_	DT	12	_	_	_	_	_	_	_	I-Time
13	potentially	_	potentially	_	RB	12	_	_	_	_	_	_	_	I-Time
14	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Time
15	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Time
16	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Time
17	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Time
18	agonists	_	UNK	_	NNS	12	_	_	_	_	_	_	_	I-Time
19	for	_	for	_	IN	12	_	_	_	_	_	_	_	I-Time
20	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Time
21	use	_	use	_	NN	12	_	_	_	_	_	use.n	Ingest_substance	O
22	disorder	_	UNK	_	NN	12	_	_	_	_	_	_	_	B-Manner
23	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	I-Manner
24	,	_	,	_	,	12	_	_	_	_	_	_	_	I-Manner
25	though	_	though	_	IN	12	_	_	_	_	_	_	_	I-Manner
26	they	_	they	_	PRP	12	_	_	_	_	_	_	_	I-Manner
27	also	_	also	_	RB	12	_	_	_	_	_	_	_	I-Manner
28	make	_	make	_	VBP	12	_	_	_	_	_	_	_	I-Manner
29	their	_	their	_	PRP$	12	_	_	_	_	_	_	_	I-Manner
30	misuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Manner
31	more	_	more	_	RBR	12	_	_	_	_	_	_	_	I-Manner
32	likely	_	likely	_	JJ	12	_	_	_	_	_	_	_	I-Manner
33	.	_	.	_	.	12	_	_	_	_	_	_	_	I-Manner

1	conclusions	_	UNK	_	NNS	12	_	_	_	_	_	_	_	B-Increment
2	:	_	:	_	:	12	_	_	_	_	_	_	_	I-Increment
3	the	_	The	_	DT	12	_	_	_	_	_	_	_	I-Increment
4	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Increment
5	amounts	_	amount	_	NNS	12	_	_	_	_	_	_	_	I-Increment
6	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Increment
7	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Increment
8	dispensed	_	UNK	_	VBN	12	_	_	_	_	_	_	_	I-Increment
9	are	_	be	_	VBP	12	_	_	_	_	_	_	_	I-Increment
10	consistent	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Increment
11	with	_	with	_	IN	12	_	_	_	_	_	_	_	I-Increment
12	the	_	the	_	DT	12	_	_	_	_	_	_	_	I-Increment
13	potentially	_	potentially	_	RB	12	_	_	_	_	_	_	_	I-Increment
14	greater	_	greater	_	JJR	12	_	_	_	_	_	_	_	I-Increment
15	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Increment
16	of	_	of	_	IN	12	_	_	_	_	_	_	_	I-Increment
17	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Increment
18	agonists	_	UNK	_	NNS	12	_	_	_	_	_	_	_	I-Increment
19	for	_	for	_	IN	12	_	_	_	_	_	_	_	I-Increment
20	opioid	_	UNK	_	JJ	12	_	_	_	_	_	_	_	I-Increment
21	use	_	use	_	NN	12	_	_	_	_	_	_	_	I-Increment
22	disorder	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Increment
23	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	I-Increment
24	,	_	,	_	,	12	_	_	_	_	_	_	_	I-Increment
25	though	_	though	_	IN	12	_	_	_	_	_	_	_	I-Increment
26	they	_	they	_	PRP	12	_	_	_	_	_	_	_	I-Increment
27	also	_	also	_	RB	12	_	_	_	_	_	_	_	I-Increment
28	make	_	make	_	VBP	12	_	_	_	_	_	_	_	I-Increment
29	their	_	their	_	PRP$	12	_	_	_	_	_	_	_	I-Increment
30	misuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	I-Increment
31	more	_	more	_	RBR	12	_	_	_	_	_	more.a	Increment	O
32	likely	_	likely	_	JJ	12	_	_	_	_	_	_	_	B-Increment
33	.	_	.	_	.	12	_	_	_	_	_	_	_	I-Increment

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	S-Time
2	changes	_	change	_	NNS	13	_	_	_	_	_	change.n	Exchange	O
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	B-Manner
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Manner
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Manner
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Manner
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Manner
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Manner
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Manner
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Manner
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Manner
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Manner
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Manner
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Manner
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Manner
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Manner
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
53	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	13	_	_	_	_	_	that.adv	Degree	O
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
53	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Required
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Required
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Required
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Required
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Required
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Required
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Required
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Required
9	policies	_	policy	_	NNS	13	_	_	_	_	_	policy.n	Law	O
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	S-Type
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	B-Required
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Required
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Required
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Required
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Required
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Required
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Required
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Required
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Required
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Required
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Required
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Required
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Required
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Required
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Required
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Required
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Required
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Required
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Required
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Required
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	B-Required
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Required
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Required

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Time
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Time
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Time
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Time
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Time
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Time
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Time
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Time
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Time
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Time
11	on	_	on	_	IN	13	_	_	_	_	_	on.prep	Being_in_operation	O
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	B-Duration
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Duration
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Duration
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
53	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Initial_correlate
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Initial_correlate
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Initial_correlate
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Initial_correlate
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Initial_correlate
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Initial_correlate
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Initial_correlate
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Initial_correlate
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Initial_correlate
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Initial_correlate
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Initial_correlate
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	increase.v	Change_position_on_a_scale	S-Degree
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	B-Explanation
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Explanation
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	B-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Manner
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Manner
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Manner
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Manner
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Manner
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Manner
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Manner
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Manner
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Manner
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Manner
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Manner
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Manner
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Manner
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Manner
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Manner
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Manner
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Manner
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Manner
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Manner
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Manner
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Manner
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Manner
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Manner

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	S-Subregion
14	number	_	number	_	NN	13	_	_	_	_	_	number.n	Be_subset_of	O
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	B-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Manner
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Manner
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Manner
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Manner
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Manner
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Manner
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Manner
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Manner
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Manner
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
53	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Age
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Age
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Age
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Age
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Age
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Age
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Age
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Age
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Age
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Age
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Age
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Age
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Age
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Age
15	of	_	of	_	IN	13	_	_	_	_	_	of.prep	Age	S-Degree
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	B-Age
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Age
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Age
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Age
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Age
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Age
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Age
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Age
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Age
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Age
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Age
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Age
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Age
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Age
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Age
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Age
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Age
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Age
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Age
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Age
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Age
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Age
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Age
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Age
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Age
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Age
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Age
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Age
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Age
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Age
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Age
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Age
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Age
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Age
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Age
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Age
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Age
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Age

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	13	_	_	_	_	_	that.adv	Degree	O
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
53	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Dangerous_entity
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Dangerous_entity
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Dangerous_entity
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Dangerous_entity
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Dangerous_entity
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Dangerous_entity
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Dangerous_entity
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Dangerous_entity
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Dangerous_entity
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Dangerous_entity
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Dangerous_entity
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Dangerous_entity
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Dangerous_entity
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Dangerous_entity
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Dangerous_entity
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	B-Situation
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Situation
23	safely	_	safely	_	RB	13	_	_	_	_	_	safely.adv	Risky_situation	B-Degree
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Degree
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Degree
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Degree
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Degree
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Degree
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Degree
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Degree
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Degree
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Degree
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Degree
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Degree
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Degree
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Degree
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Degree
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Degree
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Degree
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Degree
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Degree
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Degree
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Degree
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	B-Dangerous_entity
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Dangerous_entity
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Dangerous_entity
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Dangerous_entity
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Dangerous_entity
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Dangerous_entity
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Dangerous_entity
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Dangerous_entity
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Dangerous_entity
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Dangerous_entity

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Manner
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Manner
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Manner
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Manner
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Manner
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Manner
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Manner
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Manner
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	B-Initial_correlate
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Initial_correlate
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Initial_correlate
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Initial_correlate
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Initial_correlate
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Initial_correlate
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Initial_correlate
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Initial_correlate
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Initial_correlate
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Initial_correlate
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	increase.v	Change_position_on_a_scale	S-Degree
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	B-Manner
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Manner
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Manner
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Manner
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Manner
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Manner
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Manner
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Manner
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Manner
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Manner
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Manner
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Manner
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Manner
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Manner
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Manner
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Manner
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Manner

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Manner
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Manner
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Manner
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Manner
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Manner
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Manner
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Manner
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Manner
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	B-Time
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Time
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Time
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Time
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Time
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Time
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Time
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Time
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Time
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Time
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Time
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Time
33	use	_	use	_	NN	13	_	_	_	_	_	use.n	Ingest_substance	O
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	B-Manner
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Manner
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Manner
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Manner
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Manner
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Manner
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Manner
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Manner
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Manner
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Manner
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Manner
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Manner
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Manner
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Manner
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Manner

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Salient_entity
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Salient_entity
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Salient_entity
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Salient_entity
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Salient_entity
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Salient_entity
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Salient_entity
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Salient_entity
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Salient_entity
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Salient_entity
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Salient_entity
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Salient_entity
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Salient_entity
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Salient_entity
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Salient_entity
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Salient_entity
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Salient_entity
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Salient_entity
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Salient_entity
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Salient_entity
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Salient_entity
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Salient_entity
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Salient_entity
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Salient_entity
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	alternative.n	Alternatives	O
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	B-Purpose
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Purpose
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Purpose
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Purpose
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Purpose
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Purpose
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Purpose
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Purpose
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Purpose
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Purpose
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Purpose
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Purpose
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Purpose
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Purpose
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Purpose
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Purpose
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Purpose

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Topic
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Topic
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Topic
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Topic
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Topic
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Topic
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Topic
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Topic
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Topic
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Topic
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Topic
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Topic
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Topic
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Topic
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Topic
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Topic
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Topic
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Topic
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Topic
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Topic
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Topic
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Topic
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Topic
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Topic
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Topic
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Topic
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Topic
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Topic
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Topic
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Topic
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Topic
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Topic
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Topic
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Topic
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Topic
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Topic
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Topic
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Topic
39	opening	_	open	_	VBG	13	_	_	_	_	_	open.v	Candidness	S-Degree
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	B-Addressee
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Addressee
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Addressee
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Addressee
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Addressee
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Addressee
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Addressee
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Addressee
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Addressee
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Addressee
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Addressee
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Addressee
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Addressee
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Addressee

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Garment
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Garment
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Garment
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Garment
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Garment
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Garment
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Garment
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Garment
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Garment
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Garment
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Garment
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Garment
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Garment
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Garment
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Garment
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Garment
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Garment
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Garment
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Garment
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Garment
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Garment
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Garment
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Garment
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Garment
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Garment
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Garment
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Garment
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Garment
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Garment
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Garment
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Garment
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Garment
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Garment
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Garment
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Garment
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Garment
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Garment
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Garment
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Garment
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Garment
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	I-Garment
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Garment
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	I-Garment
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	I-Garment
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	I-Garment
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	I-Garment
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	S-Subregion
48	overall	_	overall	_	JJ	13	_	_	_	_	_	overall.n	Clothing	O
49	number	_	number	_	NN	13	_	_	_	_	_	_	_	B-Garment
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Garment
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Garment
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Garment
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Garment

1	the	_	The	_	DT	13	_	_	_	_	_	_	_	B-Manner
2	changes	_	change	_	NNS	13	_	_	_	_	_	_	_	I-Manner
3	after	_	after	_	IN	13	_	_	_	_	_	_	_	I-Manner
4	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
5	2006	_	2006	_	CD	13	_	_	_	_	_	_	_	I-Manner
6	legislation	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
7	suggest	_	suggest	_	VBP	13	_	_	_	_	_	_	_	I-Manner
8	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
9	policies	_	policy	_	NNS	13	_	_	_	_	_	_	_	I-Manner
10	focused	_	focus	_	VBD	13	_	_	_	_	_	_	_	I-Manner
11	on	_	on	_	IN	13	_	_	_	_	_	_	_	I-Manner
12	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Manner
14	number	_	number	_	NN	13	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Manner
16	patients	_	patient	_	NNS	13	_	_	_	_	_	_	_	I-Manner
17	that	_	that	_	IN	13	_	_	_	_	_	_	_	I-Manner
18	a	_	a	_	DT	13	_	_	_	_	_	_	_	I-Manner
19	single	_	single	_	JJ	13	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
21	physician	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
22	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
23	safely	_	safely	_	RB	13	_	_	_	_	_	_	_	I-Manner
24	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Manner
25	effectively	_	effectively	_	RB	13	_	_	_	_	_	_	_	I-Manner
26	treat	_	treat	_	NN	13	_	_	_	_	_	_	_	I-Manner
27	could	_	could	_	MD	13	_	_	_	_	_	_	_	I-Manner
28	unk	_	UNK	_	VB	13	_	_	_	_	_	_	_	I-Manner
29	effective	_	effective	_	JJ	13	_	_	_	_	_	_	_	I-Manner
30	in	_	in	_	IN	13	_	_	_	_	_	_	_	I-Manner
31	increasing	_	increase	_	VBG	13	_	_	_	_	_	_	_	I-Manner
32	buprenorphine	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Manner
33	use	_	use	_	NN	13	_	_	_	_	_	_	_	I-Manner
34	than	_	than	_	IN	13	_	_	_	_	_	_	_	I-Manner
35	would	_	would	_	MD	13	_	_	_	_	_	_	_	I-Manner
36	alternatives	_	alternative	_	NNS	13	_	_	_	_	_	_	_	I-Manner
37	such	_	such	_	JJ	13	_	_	_	_	_	_	_	I-Manner
38	as	_	a	_	IN	13	_	_	_	_	_	_	_	I-Manner
39	opening	_	open	_	VBG	13	_	_	_	_	_	_	_	I-Manner
40	new	_	new	_	JJ	13	_	_	_	_	_	_	_	I-Manner
41	substance	_	substance	_	NN	13	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	13	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	13	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	13	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	13	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	13	_	_	_	_	_	_	_	B-Subregion
48	overall	_	overall	_	JJ	13	_	_	_	_	_	_	_	I-Subregion
49	number	_	number	_	NN	13	_	_	_	_	_	number.n	Be_subset_of	O
50	of	_	of	_	IN	13	_	_	_	_	_	_	_	B-Manner
51	unk	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Manner
52	physicians	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Manner
53	.	_	.	_	.	13	_	_	_	_	_	_	_	I-Manner

